250 related articles for article (PubMed ID: 10408539)
1. 1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla.
Pioro EP; Majors AW; Mitsumoto H; Nelson DR; Ng TC
Neurology; 1999 Jul; 53(1):71-9. PubMed ID: 10408539
[TBL] [Abstract][Full Text] [Related]
2. Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis.
Atassi N; Xu M; Triantafyllou C; Keil B; Lawson R; Cernasov P; Ratti E; Long CJ; Paganoni S; Murphy A; Salibi N; Seethamraju R; Rosen B; Ratai EM
PLoS One; 2017; 12(5):e0177680. PubMed ID: 28498852
[TBL] [Abstract][Full Text] [Related]
3. MR spectroscopy in amyotrophic lateral sclerosis/motor neuron disease.
Pioro EP
J Neurol Sci; 1997 Oct; 152 Suppl 1():S49-53. PubMed ID: 9419054
[TBL] [Abstract][Full Text] [Related]
4. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS.
Rooney WD; Miller RG; Gelinas D; Schuff N; Maudsley AA; Weiner MW
Neurology; 1998 Jun; 50(6):1800-5. PubMed ID: 9633731
[TBL] [Abstract][Full Text] [Related]
5. Quantitative short echo time proton magnetic resonance spectroscopic imaging study of malformations of cortical development causing epilepsy.
Woermann FG; McLean MA; Bartlett PA; Barker GJ; Duncan JS
Brain; 2001 Feb; 124(Pt 2):427-36. PubMed ID: 11157569
[TBL] [Abstract][Full Text] [Related]
6. The ratio of N-acetyl aspartate to glutamate correlates with disease duration of amyotrophic lateral sclerosis.
Sako W; Abe T; Izumi Y; Harada M; Kaji R
J Clin Neurosci; 2016 May; 27():110-3. PubMed ID: 26765768
[TBL] [Abstract][Full Text] [Related]
7. An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy.
Foerster BR; Pomper MG; Callaghan BC; Petrou M; Edden RA; Mohamed MA; Welsh RC; Carlos RC; Barker PB; Feldman EL
JAMA Neurol; 2013 Aug; 70(8):1009-16. PubMed ID: 23797905
[TBL] [Abstract][Full Text] [Related]
8. Brainstem metabolites in multiple system atrophy of cerebellar type: 3.0-T magnetic resonance spectroscopy study.
Takado Y; Igarashi H; Terajima K; Shimohata T; Ozawa T; Okamoto K; Nishizawa M; Nakada T
Mov Disord; 2011 Jun; 26(7):1297-302. PubMed ID: 21370263
[TBL] [Abstract][Full Text] [Related]
9. Study of the features of proton MR spectroscopy ((1)H-MRS) on amyotrophic lateral sclerosis.
Han J; Ma L
J Magn Reson Imaging; 2010 Feb; 31(2):305-8. PubMed ID: 20099342
[TBL] [Abstract][Full Text] [Related]
10. Regional distributions of brain glutamate and glutamine in normal subjects.
Goryawala MZ; Sheriff S; Maudsley AA
NMR Biomed; 2016 Aug; 29(8):1108-16. PubMed ID: 27351339
[TBL] [Abstract][Full Text] [Related]
11. Neurochemical correlates of functional decline in amyotrophic lateral sclerosis.
Cheong I; Deelchand DK; Eberly LE; Marjańska M; Manousakis G; Guliani G; Walk D; Öz G
J Neurol Neurosurg Psychiatry; 2019 Mar; 90(3):294-301. PubMed ID: 30467209
[TBL] [Abstract][Full Text] [Related]
12. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings.
Ellis CM; Simmons A; Andrews C; Dawson JM; Williams SC; Leigh PN
Neurology; 1998 Oct; 51(4):1104-9. PubMed ID: 9781537
[TBL] [Abstract][Full Text] [Related]
13. Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
Niessen HG; Debska-Vielhaber G; Sander K; Angenstein F; Ludolph AC; Hilfert L; Willker W; Leibfritz D; Heinze HJ; Kunz WS; Vielhaber S
Eur J Neurosci; 2007 Mar; 25(6):1669-77. PubMed ID: 17432958
[TBL] [Abstract][Full Text] [Related]
14. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.
Suhy J; Miller RG; Rule R; Schuff N; Licht J; Dronsky V; Gelinas D; Maudsley AA; Weiner MW
Neurology; 2002 Mar; 58(5):773-9. PubMed ID: 11889242
[TBL] [Abstract][Full Text] [Related]
15. Proton MR spectroscopy detected glutamate/glutamine is increased in children with traumatic brain injury.
Ashwal S; Holshouser B; Tong K; Serna T; Osterdock R; Gross M; Kido D
J Neurotrauma; 2004 Nov; 21(11):1539-52. PubMed ID: 15684647
[TBL] [Abstract][Full Text] [Related]
16. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study.
Rule RR; Suhy J; Schuff N; Gelinas DF; Miller RG; Weiner MW
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5(3):141-9. PubMed ID: 15512902
[TBL] [Abstract][Full Text] [Related]
17. Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy.
Simister RJ; McLean MA; Barker GJ; Duncan JS
Neurology; 2003 Oct; 61(7):897-902. PubMed ID: 14557556
[TBL] [Abstract][Full Text] [Related]
18. Short echo-time Magnetic Resonance Spectroscopy in ALS, simultaneous quantification of glutamate and GABA at 3 T.
Blicher JU; Eskildsen SF; Stærmose TG; Møller AT; Figlewski K; Near J
Sci Rep; 2019 Nov; 9(1):17593. PubMed ID: 31772352
[TBL] [Abstract][Full Text] [Related]
19. Creatine supplementation lowers brain glutamate levels in Huntington's disease.
Bender A; Auer DP; Merl T; Reilmann R; Saemann P; Yassouridis A; Bender J; Weindl A; Dose M; Gasser T; Klopstock T
J Neurol; 2005 Jan; 252(1):36-41. PubMed ID: 15672208
[TBL] [Abstract][Full Text] [Related]
20. In vivo measurements of glutamine + glutamate (Glx) and N-acetyl aspartate (NAA) levels in human partial epilepsy.
Savic I; Thomas AM; Ke Y; Curran J; Fried I; Engel J
Acta Neurol Scand; 2000 Sep; 102(3):179-88. PubMed ID: 10987378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
